New topical drugs for open-angle glaucoma.

Article Details

Citation

Copy to clipboard

Authors unspecified

New topical drugs for open-angle glaucoma.

Drug Ther Bull. 2003 Feb;41(2):12-4.

PubMed ID

12630335 [ View in PubMed

]

Abstract

When we reviewed the management of open-angle glaucoma in 1997, the topical drug treatments available included beta-blockers, a carbonic anhydrase inhibitor (dorzolamide), an alpha 2 agonist (apraclonidine), a prostaglandin analogue (latanoprost) and a variety of miotics and sympathomimetics. We concluded that a beta-blocker was the treatment of first choice. Here, we review seven new topical preparations that have been marketed, or had their licensed indications changed, since our earlier article.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Apraclonidine	Alpha-2A adrenergic receptor	Protein	Humans	Yes	Agonist	Details